title: Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).
authors.affiliation: Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA. horlocker.terese@mayo.edu
authors.forename: Terese T
authors.initials: TT
authors.lastname: Horlocker
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Wedel
authors.forename: Honorio
authors.initials: H
authors.lastname: Benzon
authors.forename: David L
authors.initials: DL
authors.lastname: Brown
authors.forename: F Kayser
authors.initials: FK
authors.lastname: Enneking
authors.forename: John A
authors.initials: JA
authors.lastname: Heit
authors.forename: Michael F
authors.initials: MF
authors.lastname: Mulroy
authors.forename: Richard W
authors.initials: RW
authors.lastname: Rosenquist
authors.forename: John
authors.initials: J
authors.lastname: Rowlingson
authors.forename: Michael
authors.initials: M
authors.lastname: Tryba
authors.forename: Chun-Su
authors.initials: CS
authors.lastname: Yuan
mesh_terms: D000765:Anesthesia, Conduction; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D017408:Guidelines as Topic; D006408:Hematoma, Subdural / Q000209:etiology; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control / Q000628:therapy
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors